Summary
Please note: purchasing the PDF version of this product you are recieving a global user license
The first edition of the BioPlan China Biopharmaceutical Index includes the Top 60 Biopharmaceutical Companies in China, with detailed profiles of their business focus, products, revenues, R&D and business strategies, international objectives, partnering strategies, and marketing activities.
In addition, subscribers will receive on-going updates to activities and trends in China as the country's biopharmaceutical industry expands. Our China Biopharmaceutical Index and our Top 60 Directory provide you information on trending of activities and changes occurring in the region. Be sure to keep up-to-date on Who's Who in China. This report will help ensure you're current, and have a solid understanding of this dynamic, rapidly changing market.
- 305 pages
- 60 full profiles
- 123 key Chinese-owned biopharmaceutical organizations listed
- 81 recombinant and protein therapeutic biopharmaceutical companies
- 42 vaccines and blood products manufacturers
- Updated Quarterly
|
